The vaccine's trials show it suppresses tumor and potential metastases
December 16, 2024 00:00:00
Earlier, Director of the Gamaleya National Research Center for Epidemiology and Microbiology Alexander Gintsburg told TASS that the vaccine's pre-clinical trials had shown that it suppresses tumor development and potential metastases.
